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A BASIC Computer Program for Use

In Evaluating Enzyme-SubstrateinhibItor Kinetics
To the Editor:
In characterizing the apparent kinetic mechanism for an enzyme, the first step is to evaluate whether Michaelian kinetics apply and, if so, to obtain the best estimate of the maximal velocity (Vm) and the MichaelisMenten constant (Km). When characterizing an inhibitor of a reaction involving a single substrate, one must discern the mechanism of inhibition. Several classical models have been described in detail (1). In short, by "competitive," one implies that the effect of the inhibitor is entirely on Km: the inhibitor increases the effective Km. In an "uncompetitive" model there is an effect on Km and a proportional effect on Vm. In the classic "non-competitive" models there is an effect on Vm but no effect on Km. Finally, one has the "mixed non-noncompetitive" mechanisms, in which there are effects on both Km and Vm, but these effects are not necessarily directly proportional. The term "pure" implies that the enzyme-inhibitor-substrate complex is completely inactive, whereas the term "partial" implied that this complex can still catalyze the reaction and form the product (1).
We We utilize the observed reaction velocity as the dependent variable, and take into account the non-constant percentage error in this measurement.
Weighting is performed in this program by using a power function (HP-85 version), or a quadratic polynomial function (DEC-10 version), or both. The program can be utilized to permit the investigator to obtain automatic initial estimates of Vm and Km, then try each of several models for an inhibitor. In addition, the investigator can select the best model in terms of root mean square error and other criteria for goodness of fit. The program gives a warning in case the points are not randomly distributed around the predicted curve. The best model is selected on the basis of the "extra sum of squares" principle, when the models under consideration have a different number of parameters. The program provides graphical display, either in terms of reaction velocity vs substrate concentration (hyperbolic plot), or linearized in terms of Lineweaver-Burk plots. The DEC-10 version uses OMNIGRAPH and Tektronix terminals for graphical display, whereas for the HP-85 version a 7225B plotter can be used.
We have successfully used this program in the evaluation of the inhibition of thymidylate synthetase by methotrexate polyglutainates (3) and for several other applications. Syva Corp., Palo Alto, CA) will undoubtedly have an impact on many current strategies in use for drug screening. The assay was developed expressly for application to emergency toxicology screening and is said to be "more than sensitive enough to detect concentrations of the analytes at levels compatible with overdoses" (4). However, non-toxic amounts of benzodiazepines will usually not be detected. This presents an obvious difficulty when one is screening urine from infants and children, because singletablet ingestions are common in this group and can produce symptoms and signs compatible with drug overdose, but at concentrations in urine below the detection limits of this procedure (i.e., equivalent to 1.7 mol of oxazepam per liter). We examined a simple modification to the recommended procedure that would facilitate its use in pediatric practice.
